相关实验视频

Updated: Jun 20, 2025

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

除了乳腺癌之外的HER2向疗法 - 一个更新

Jeesun Yoon¹, Do-Youn Oh^2,3,4

¹Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

Nature reviews. Clinical oncology

|July 22, 2024

概括

包括突变在内的HER2变异在乳腺癌和胃癌之外的各种固体瘤中越来越多地被识别出来. 新的针对HER2的疗法显示出更广泛的应用和改善患者治疗结果的前景.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

HER2 (ErbB2) 是乳腺癌和胃癌中验证的治疗标,通过过度表达或放大来确定.
分子分析的进步揭示了各种固体瘤中的各种HER2变异,包括突变.
对于乳腺癌和胃癌以外的固体瘤,存在有限的针对HER2的治疗方法.

研究的目的:

审查目前针对乳腺癌和胃癌以外的固体瘤的HER2向疗法的现状.
讨论新的HER2导向治疗策略和未来的方向.
为突出开发HER2向药物的新指示和监管批准的进展.

主要方法:

关于 HER2 向疗法开发近期进展的文献综述.
对HER2向药物的临床试验数据和监管批准的分析.
探索新兴的治疗策略,以克服耐药性.

主要成果:

在开发具有多种作用机制的创新HER2向疗法方面取得了重大进展.
扩大治疗选择超越传统的HER2过度表达/放大,包括HER2突变.
最近批准了对HER2过度表达的固体瘤的trastuzumab deruxtecan.

结论:

针对HER2的疗法正在迅速发展,为各种固体瘤患者提供了新的希望.
未来的战略重点是克服耐药性,以提高疗效和改善患者的治疗结果.
新型针对HER2的治疗方法的开发正在扩大瘤学的治疗可能性.

更多相关视频

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...